We’ve recently updated our valuation analysis.

CNB Financial Valuation

Is 44I undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 44I?

Other financial metrics that can be useful for relative valuation.

44I key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ratio-1x

Price to Earnings Ratio vs Peers

How does 44I's PE Ratio compare to its peers?

The above table shows the PE ratio for 44I vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average11.8x
PCZ ProCredit Holding KGaA
8.5x19.8%€406.4m
UBK UmweltBank
20.6xn/a€398.6m
MBK Merkur PrivatBank KgaA
10x-1.6%€119.8m
SMBK SmartFinancial
8.1x-3.8%US$373.7m
44I CNB Financial
6x-6.0%€372.0m

Price-To-Earnings vs Peers: 44I is good value based on its Price-To-Earnings Ratio (6x) compared to the peer average (11.8x).


Price to Earnings Ratio vs Industry

How does 44I's PE Ratio compare vs other companies in the European Banks Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a2.4%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a2.4%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 44I is good value based on its Price-To-Earnings Ratio (6x) compared to the European Banks industry average (8.6x)


Price to Earnings Ratio vs Fair Ratio

What is 44I's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

44I PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6x
Fair PE Ratio10.3x

Price-To-Earnings vs Fair Ratio: 44I is good value based on its Price-To-Earnings Ratio (6x) compared to the estimated Fair Price-To-Earnings Ratio (10.3x).


Share Price vs Fair Value

What is the Fair Price of 44I when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 44I (€16.3) is trading below our estimate of fair value (€59.78)

Significantly Below Fair Value: 44I is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 44I forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€16.30
€21.82
+33.9%
2.1%€22.29€21.36n/a2
May ’24€16.40
€22.33
+36.2%
2.0%€22.79€21.88n/a2
Apr ’24€17.20
€26.55
+54.3%
1.8%€27.01€26.08n/a2
Mar ’24€22.20
€26.55
+19.6%
1.8%€27.01€26.08n/a2
Feb ’24€21.80
€26.25
+20.4%
1.8%€26.71€25.79n/a2
Jan ’24€22.00
€30.32
+37.8%
3.2%€31.69€29.64n/a3
Dec ’23€24.00
€30.32
+26.3%
3.2%€31.69€29.64n/a3
Nov ’23€25.20
€30.32
+20.3%
3.2%€31.69€29.64n/a3
Oct ’23€23.60
€30.05
+27.3%
4.1%€31.35€28.41n/a3
Sep ’23€26.00
€30.05
+15.6%
4.1%€31.35€28.41n/a3
Aug ’23€24.80
€30.05
+21.2%
4.1%€31.35€28.41n/a3
Jul ’23€22.60
€28.74
+27.2%
2.6%€29.66€27.81n/a3
Jun ’23€23.00
€28.74
+24.9%
2.6%€29.66€27.81n/a3
May ’23€23.60
€28.74
+21.8%
2.6%€29.66€27.81€16.403
Apr ’23€23.40
€28.23
+20.6%
2.6%€29.14€27.32€17.203
Mar ’23€22.80
€26.85
+17.7%
1.5%€27.14€26.26€22.203
Feb ’23€23.40
€27.52
+17.6%
1.5%€27.82€26.92€21.803
Jan ’23€23.40
€25.29
+8.1%
3.2%€25.86€24.14€22.003
Dec ’22€22.80
€25.29
+10.9%
3.2%€25.86€24.14€24.003
Nov ’22€21.80
€25.29
+16.0%
3.2%€25.86€24.14€25.203
Oct ’22€20.60
€24.24
+17.7%
1.6%€24.52€23.68€23.603
Sep ’22€20.40
€24.29
+19.1%
1.6%€24.57€23.73€26.003
Aug ’22€19.30
€24.29
+25.9%
1.6%€24.57€23.73€24.803
Jul ’22€19.00
€23.54
+23.9%
1.7%€24.09€23.26€22.603
Jun ’22€19.50
€23.54
+20.7%
1.7%€24.09€23.26€23.003
May ’22€20.40
€23.54
+15.4%
1.7%€24.09€23.26€23.603

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies